Hormone combination shows promise in the treatment of obesity and diabetes

A new treatment combining two hormones can reduce appetite, according to new research. This early study provides 'first in human' evidence that a combined therapy using the hormones glucagon and glucagon-like peptide 1 (GLP-1) may form the basis for a new treatment for obesity and diabetes in the future.

URL: http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/obesity/~3/3n4Yah8XixU/130318203332.htm